Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
635K
-
Shares change
-
-575K
-
Total reported value, excl. options
-
$756K
-
Value change
-
-$869K
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$1.19
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2016
13 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q4 2016.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 635K shares
of 112M outstanding shares and own 0.57% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (270K shares), RENAISSANCE TECHNOLOGIES LLC (163K shares), GRT CAPITAL PARTNERS L.L.C. (95K shares), GEODE CAPITAL MANAGEMENT, LLC (31.3K shares), GOLDMAN SACHS GROUP INC (29.2K shares), NORTHERN TRUST CORP (17K shares), MORGAN STANLEY (15.6K shares), Acrospire Investment Management LLC (10.8K shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.81K shares), and BlackRock Fund Advisors (703 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.